glomerulonephritis

Newark, New Castle, USA, May 31, 2023 (GLOBE NEWSWIRE) -- The market analysis of the global pauci-immune glomerulonephritis treatment market was conducted by Growth Plus Reports in 2022. The market is expected to hit a revenue CAGR of …

<!-- Name:DistributionId Value:8824774 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False --> <!-- Name:IcbCode Value: -->…

Study found that dapagliflozin markedly reduces the risk of progressive loss of renal function in patients with chronic kidney disease (CKD), both in the presence and in the absence of diabetes mellitus. The trial included 115…